SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-23-250823
Filing Date
2023-10-04
Accepted
2023-10-04 17:26:27
Documents
2
Group Members
PANACEA INNOVATION LTDPANACEA OPPORTUNITY FUND I GP COMPANY, LTD.PANACEA OPPORTUNITY FUND I, L.P.PANACEA VENTURE HEALTHCARE FUND II GP COMPANY, LTDPANACEA VENTURE HEALTHCARE FUND II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d454741dsc13ga.htm SC 13G/A 123524
2 EX-99 d454741dex99.htm EX-99 8880
  Complete submission text file 0001193125-23-250823.txt   133936
Mailing Address 9620 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address
Huang James (Filed by) CIK: 0001573160 (see all company filings)

Type: SC 13G/A

Mailing Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Subject) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92416 | Film No.: 231308986
SIC: 2834 Pharmaceutical Preparations